Table 2 Laboratory values
First author and publication datenHbtarget (g/dl)Baseline Hb (g/dl)Hb at end (g/dl)Baseline creatinine (mg/dl)Creatinine at end (mg/dl)
PlaceboESPPlaceboESPPlaceboESPPlaceboESP
Parissis, 2008173214.011.4 (0.7)11.0 (0.8)11.8 (1.3)12.8 (1.3)1.7 (0.4)1.8 (0.5)N/AN/A
Ghali, 2008431914.011.3 (10.7–11.9)11.5 (11.0–12.0)Δ 0.5 (−0.3–1.2)Δ 2.1 (1.3–2.8)1.4 (1.2–1.8)1.5 (1.1–1.9)N/AN/A
Van Veldhuisen, 2007516514.011.4 (0.9)11.5 (0.7)11.4 (1.4)13.3 (1.2)1.5 (0.6)1.4 (0.5)1.6 (0.8)1.3 (0.5)
Ponikowski, 2007184113.0–15.011.6 (0.2)11.8 (0.2)12.3 (0.4)13.9 (0.4)1.4 (0.5)1.3 (0.5)1.4 (0.4)1.2 (0.4)
Mancini, 20031623Ht >45%10.9 (1.3)11.0 (0.6)11.5 (1.3)14.3 (1.2)1.6 (0.5)1.6 (0.4)NANA
Palazzuoli, 200663811.5–12.010.6 (0.7)10.4 (0.6)10.5 (0.6)12.4 (0.8)2.4 (0.6)2.5 (0.3)1.8 (0.4)2.2 (0.5)
Silverberg, 200173212.510.9 (0.8)10.3 (1.2)10.8 (0.8)12.9 (1.1)1.4 (0.9)1.7 (0.8)1.8 (0.5)1.7 (0.7)
  • Results are shown as mean (SD) or median (range).

  • ESP, erythropoietin-stimulating protein; Hb, haemoglobin.